PRDX2 and ovarian cancer: High PRDX2 expression was not linked to OS among all ovarian cancer patients treated with Platin, Taxol, and Taxol+Platin chemotherapy, but results among these three chemotherapeutic agents showed a better PFS in all ovarian cancer patients.